Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.

Autor: Paz-Ares LG; Hospital Universitario 12 de Octubre, H12O-CNIO Lung Cancer Unit, Complutense University and Ciberonc, Madrid, Spain., Juan-Vidal O; Hospital Universitari i Politécnic La Fe de Valencia, Valencia, Spain., Mountzios GS; Henry Dunant Hospital Center, Athens, Greece., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Reinmuth N; Asklepios Lung Clinic, German Center for Lung Research (DZL), Munich-Gauting, Germany., de Marinis F; European Institute of Oncology IRCCS, Milan, Italy., Girard N; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France., Patel VM; Florida Cancer Specialists and Research Institute, Ocala, FL., Takahama T; Kindai University, Osaka, Japan., Owen SP; McGill University Health Centre, Montreal, QC, Canada., Reznick DM; Rocky Mountain Cancer Center, Aurora, CO., Badin FB; Baptist Health Medical Group, Lexington, KY., Cicin I; Istinye University, Medical Center, Istanbul, Turkey., Mekan S; Gilead Sciences, Inc, Foster City, CA., Patel R; Gilead Sciences, Inc, Foster City, CA., Zhang E; Gilead Sciences, Inc, Foster City, CA., Karumanchi D; Gilead Sciences, Inc, Foster City, CA., Garassino MC; University of Chicago Comprehensive Cancer Center, Chicago, IL.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2860-2872. Date of Electronic Publication: 2024 May 31.